Home/Filings/4/0000899243-19-015276
4//SEC Filing

Farrell Edward 4

Accession 0000899243-19-015276

CIK 0001596946other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 4:05 PM ET

Size

16.7 KB

Accession

0000899243-19-015276

Insider Transaction Report

Form 4
Period: 2019-05-29
Transactions
  • Sale

    Common Stock

    2019-05-29$9.95/sh11,000$109,45014,566 total
Holdings
  • Employee Stock Option (right to buy)

    Exercise: $15.17Exp: 2025-05-19Ordinary Shares (30,000 underlying)
    30,000
  • Restricted Stock Units

    Ordinary Shares (24,515 underlying)
    24,515
  • Employee Stock Option (right to buy)

    Exercise: $11.92Exp: 2026-05-31Ordinary Shares (30,000 underlying)
    30,000
  • Options to acquire ordinary shares

    Exp: 2023-04-10Ordinary Shares (96,000 underlying)
    96,000
  • Employee Stock Option (right to buy)

    Exercise: $7.58Exp: 2027-05-23Ordinary Shares (40,000 underlying)
    40,000
  • Restricted Stock Units

    Ordinary Shares (45,000 underlying)
    45,000
  • Employee Stock Option (right to buy)

    Exercise: $8.00Exp: 2024-04-29Ordinary Shares (79,000 underlying)
    79,000
  • Multi-year Performance Based Restricted Stock Unit

    Exp: 2019-12-31Ordinary Shares (50,000 underlying)
    50,000
Footnotes (12)
  • [F1]20,000 options have vested and remain exercisable and 10,000 options will vest on June 1, 2019.
  • [F10]On May 24, 2019, the Reporting Person was granted 45,000 Restricted Stock Units, vesting in three equal annual installments beginning May 24, 2020.
  • [F11]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2019.
  • [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.91 to $10.00, inclusive. The Reporting Person undertakes to provide to Quotient Limited, any security holder of Quotient Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (12) to this Form 4.
  • [F2]All 30,000 options have vested and remain exercisable.
  • [F3]The exercise price will be paid in pounds sterling, at GBP0.003 per share.
  • [F4]All 96,000 options have vested and remain exercisable.
  • [F5]All 79,000 options have vested and remain exercisable.
  • [F6]26,666 options have vested and remain exercisable. 13,334 options will vest on May 24, 2020.
  • [F7]Each Multi-year Performance Based Restricted Stock Unit ("MRSU") represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $22.00 per share for 20 consecutive trading days during the period April 1, 2019 to December 31, 2019.
  • [F8]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  • [F9]On May 24, 2018, the Reporting Person was granted 36,773 Restricted Stock Units, of which 12,258 have vested and have been exercised. The remaining 24,515 Restricted Stock Units will vest in two equal installments on May 24, 2020 and May 24, 2021.

Issuer

Quotient Ltd

CIK 0001596946

Entity typeother

Related Parties

1
  • filerCIK 0001604629

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:05 PM ET
Size
16.7 KB